Biogen Inc (BIIB)
230.57
+0.53
(+0.23%)
USD |
NASDAQ |
May 17, 16:00
230.59
+0.02
(+0.01%)
After-Hours: 20:00
Biogen Market Cap: 33.57B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 33.57B |
| May 16, 2024 | 33.49B |
| May 15, 2024 | 34.26B |
| May 14, 2024 | 33.03B |
| May 13, 2024 | 32.81B |
| May 10, 2024 | 32.25B |
| May 09, 2024 | 32.43B |
| May 08, 2024 | 31.99B |
| May 07, 2024 | 31.87B |
| May 06, 2024 | 32.24B |
| May 03, 2024 | 31.67B |
| May 02, 2024 | 31.09B |
| May 01, 2024 | 31.47B |
| April 30, 2024 | 31.28B |
| April 29, 2024 | 31.38B |
| April 26, 2024 | 30.42B |
| April 25, 2024 | 29.48B |
| April 24, 2024 | 29.41B |
| April 23, 2024 | 28.13B |
| April 22, 2024 | 28.26B |
| April 19, 2024 | 28.15B |
| April 18, 2024 | 27.59B |
| April 17, 2024 | 27.82B |
| April 16, 2024 | 28.26B |
| April 15, 2024 | 28.50B |
| Date | Value |
|---|---|
| April 12, 2024 | 28.70B |
| April 11, 2024 | 29.49B |
| April 10, 2024 | 29.18B |
| April 09, 2024 | 29.90B |
| April 08, 2024 | 29.68B |
| April 05, 2024 | 29.52B |
| April 04, 2024 | 29.73B |
| April 03, 2024 | 29.88B |
| April 02, 2024 | 30.07B |
| April 01, 2024 | 31.11B |
| March 28, 2024 | 31.34B |
| March 27, 2024 | 31.45B |
| March 26, 2024 | 30.82B |
| March 25, 2024 | 31.50B |
| March 22, 2024 | 31.70B |
| March 21, 2024 | 32.09B |
| March 20, 2024 | 31.71B |
| March 19, 2024 | 31.78B |
| March 18, 2024 | 31.89B |
| March 15, 2024 | 31.88B |
| March 14, 2024 | 31.92B |
| March 13, 2024 | 32.93B |
| March 12, 2024 | 33.05B |
| March 11, 2024 | 33.44B |
| March 08, 2024 | 32.45B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
27.47B
Minimum
May 09 2022
62.44B
Maximum
Jun 10 2021
40.73B
Average
40.75B
Median
Oct 04 2019
Market Cap Benchmarks
| Ionis Pharmaceuticals Inc | 5.446B |
| Eli Lilly and Co | 731.81B |
| Bristol-Myers Squibb Co | 89.25B |
| Sage Therapeutics Inc | 704.13M |
| Vertex Pharmaceuticals Inc | 114.89B |
Market Cap Related Metrics
| PE Ratio | 28.79 |
| PS Ratio | 3.472 |
| Price to Book Value | 2.207 |
| Price to Free Cash Flow | 26.12 |
| Price | 230.57 |
| Earnings Yield | 3.47% |
| Operating PE Ratio | 17.81 |
| Normalized PE Ratio | 21.23 |